Journal of affective disorders

Midday timing from digital data as a marker of daily rhythm type in bipolar disorder

Updated

Abstract

Participants with bipolar disorder had a significantly delayed daytime midpoint of 16:49:07 compared to healthy controls at 16:12:51 (p < 0.01).

  • Bipolar disorder is associated with greater variability in daytime activity midpoints compared to healthy controls.
  • Females and adolescents with bipolar disorder exhibited more pronounced delays and variability in daytime midpoints.
  • Adults with bipolar disorder showed increased variability in daytime activity midpoints relative to controls.
  • Daytime midpoints calculated from wrist actigraphy correlated highly with sleep midpoints, indicating potential overlap in sleep and activity patterns.
  • The daytime midpoint mean was also significantly correlated with results from the Composite Scale of Morningness.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Conflicts of Interests. Drs. Kaufmann, Gershon, and Depp report no financial relationships with commercial interests. Dr. Miller has received Grant/Research Support from Merck & Co., Inc. and Sunovion Pharmaceuticals. Dr. Zeitzer has received grant and travel support from Merck Pharmaceuticals, grant support from Soraa, grant support and consulting fees from Vanda Pharmaceuticals, consulting fees from Google X and Delos, and is an unpaid scientific advisor to LumosTech. Dr. Ketter has received Grant/Research Support from the Agency for Healthcare Research and Quality, AstraZeneca Pharmaceuticals LP, Cephalon Inc., Eli Lilly and Company, National Institute of Mental Health, Pfizer Inc., and Sunovion Pharmaceuticals; Consultant Fees from Allergan, Inc., Avanir Pharmaceuticals, Bristol-Myers Squibb Company, Cephalon Inc., Forest Pharmaceuticals, Janssen Pharmaceutica Products, LP, Merck & Co., Inc., Sunovion Pharmaceuticals, and Teva Pharmaceuticals; Lecture Honoraria from Abbott Laboratories, Inc., AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Otsuka Pharmaceuticals; and Publication Royalties from American Psychiatric Publishing, Inc. In addition, Dr. Ketter’s spouse is an employee of and holds stock in Janssen Pharmaceuticals.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free